Market access for health technologies is rarely a straight line.
Regulatory complexity, reimbursement variability, fragmented adoption channels, and the cost of generating the right evidence at the right time create friction at every stage of a product's journey, from early development through to commercialization. IMPINGO was built to remove that friction, connecting the strategic, scientific, and commercial dots that determine whether a health technology reaches the patients and systems that need it.
